Nicklaus Ashburn to Risk Assessment
This is a "connection" page, showing publications Nicklaus Ashburn has written about Risk Assessment.
Connection Strength
0.860
-
Lumia S, Iobst W, Khan Z, Sokolosky S, Hutchison BT, Guzik A, Wittler MA, Reynolds PS, Ashburn NP. Performance of the ABCD2 Score in a US Emergency Department Observation Unit. Crit Pathw Cardiol. 2026 Mar 01; 25(1):e0413.
Score: 0.161
-
Ashburn NP, Snavely AC, Ehrig MR, Shapiro MD, Herrington DM, Reboussin DM, Gesell SB, Mahler SA. Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial. Crit Pathw Cardiol. 2025 Sep 01; 24(3):e0390.
Score: 0.152
-
Ashburn NP, Snavely AC, Supples MW, Millard MJ, Allen BR, Christenson RH, Madsen T, Mumma BE, Hashemian T, Wilkerson RG, Mahler SA. Performance of the High-STEACS Early Rule Out Pathway Using hs-cTnT at 30 Days in a Multisite US Cohort. Circ Cardiovasc Qual Outcomes. 2025 Feb; 18(2):e011084.
Score: 0.149
-
Ashburn NP, O'Neill JC, Stopyra JP, Mahler SA. Scoring systems for the triage and assessment of short-term cardiovascular risk in patients with acute chest pain. Rev Cardiovasc Med. 2021 Dec 22; 22(4):1393-1403.
Score: 0.120
-
Snavely AC, Hunter CJ, Jackson L, Stopyra JP, Ashburn NP, Supples MW, Christenson R, Miller CD, Mahler SA. Diagnostic performance of the Myocardial-Ischaemic-Injury index machine-learning algorithm in patients with an initial indeterminate troponin. Open Heart. 2026 Jan 06; 13(1).
Score: 0.040
-
Wilkerson RG, Ashburn NP, Snavely AC, Allen BR, Christenson RH, Weaver M, Zhang X, Madsen TE, Mumma BE, Supples MW, Mahler SA. Performance of High-Sensitivity Troponin T Risk Stratification Strategies for 90-day Cardiac Death or Myocardial Infarction. Crit Pathw Cardiol. 2025 Sep 01; 24(3):e0397.
Score: 0.039
-
Supples MW, Dameron AG, Powell S, Snavely AC, Ashburn NP, Allen BR, Christenson RH, Wilkerson RG, Mumma BE, Madsen TE, Mahler SA. The HET (history, electrocardiogram, and troponin) score has low efficacy and negative predictive value in a multisite U.S. cohort study. Am J Emerg Med. 2025 Mar; 89:151-158.
Score: 0.037
-
Veasey CJ, Snavely AC, Kearns ZL, Ashburn NP, Hashemian T, Mahler SA. The High-Sensitivity HEART Pathway Safely Reduces Hospitalizations Regardless of Sex or Race in a Multisite Prospective US Cohort. Clin Cardiol. 2024 Oct; 47(10):e70027.
Score: 0.037
-
Millard MJ, Ashburn NP, Snavely AC, Hashemian T, Supples M, Allen B, Christenson R, Madsen T, McCord J, Mumma B, Stopyra J, Wilkerson RG, Mahler SA. European Society of Cardiology 0/1-hour algorithm (high-sensitivity cardiac troponin T) performance across distinct age groups. Heart. 2024 May 23; 110(12):838-845.
Score: 0.036
-
Supples MW, Snavely AC, Ashburn NP, Allen BR, Mahler SA. Response to "troponin thresholds for MI risk stratification" by Dr. Pickering. Acad Emerg Med. 2024 Mar; 31(3):306-307.
Score: 0.035
-
Stopyra JP, Snavely AC, Smith LM, Harris RD, Nelson RD, Winslow JE, Alson RL, Pomper GJ, Riley RF, Ashburn NP, Hendley NW, Gaddy J, Woodrum T, Fornage L, Conner D, Alvarez M, Pflum A, Koehler LE, Miller CD, Mahler SA. Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events. PLoS One. 2020; 15(10):e0239460.
Score: 0.028
-
Smith LM, Ashburn NP, Snavely AC, Stopyra JP, Lenoir KM, Wells BJ, Hiestand BC, Herrington DM, Miller CD, Mahler SA. Identification of very low-risk acute chest pain patients without troponin testing. Emerg Med J. 2020 Nov; 37(11):690-695.
Score: 0.027